Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00939289 · ClinicalTrials.gov registry record
Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM)
A clinical trial, sponsored by DexCom.
- Completed
- Registry status
- 14
- Enrollment target
NCT00939289 is a clinical trial that has completed, run by DexCom. The registered enrollment target is 14 participants.
The verdict
NCT00939289 has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate performance of the SEVEN System and the Navigator System when both devices are worn concurrently by subjects with type 1 diabetes mellitus.
Interventions
- DEVICE Continuous Glucose Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00939289
The ClinicalTrials.gov registry entry for NCT00939289 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring is the first listed.
NCT00939289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00939289 about?
NCT00939289 is a clinical study titled "Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM)". The purpose of this pilot study is to evaluate performance of the SEVEN System and the Navigator System when both devices are worn concurrently by subjects with type 1 diabetes mellitus.
What is the current status of trial NCT00939289?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2008-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00939289?
The interventions under investigation include: Continuous Glucose Monitoring (DEVICE).
Who is sponsoring clinical trial NCT00939289?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.